Sun Pharma Advanced Research Co. Director Retires, CEO Appointed MD

Sun Pharma Advanced Research Company Ltd (SPARC) announced a change in its directorship. Dr. Rajamannar Thennati will retire from the Board of Directors upon completion of his term at the 21st Annual General Meeting on August 10, 2026. Concurrently, Mr. Anil Raghavan, the current Chief Executive Officer (CEO), has been appointed as the Managing Director and Chief Executive Officer, effective August 11, 2026. This appointment is subject to shareholder approval at the upcoming AGM. Mr. Raghavan is not related to any existing directors and has no disqualifications from SEBI. His profile highlights extensive experience in consulting and a deep interest in pharmaceutical R&D and healthcare delivery.